AstraZeneca faces lawsuits over Seroquel
AstraZeneca sales over $5 billion a year worldwide from its drug Seroquel alone. Recently it has come to the attention of the public of the astronomical lawsuit defense costs as a result of failing to adequately warn about the serious side effects the drug carries. At the present, these are only allegations. The decision is now left up to the courts to decide is this is true. The costs have exceeded the extent of the liability insurance coverage for defense costs against the medication.
Seroquel XR is AstraZeneca’s top-selling bipolar disorder treatment drug. There are over 10,000 lawsuits pending against the company related to the drug and its side effects. These include diabetes, pancreatitis, tardive dyskinesia, and death. Tardive dyskinesia is a serious adverse effect of any type of medication used to treat mental illness. It is a movement disorder that includes lip smacking, grimacing, repetitive chewing, pursing and puckering of the lips, tongue protrusion, rapid eye movements and blinking, and impaired finger movements. The longer a medication that causes this movement disorder is taken, the worse it becomes. To make matters worse, tardive dyskinesia is not reversible.
AstraZeneca’s lawsuits over Seroquel relate to the reasons Seroquel is given. Seroquel is given twice a day for schizophrenia and is sometimes given for bipolar disease. Bipolar disease is also known a manic-depressive disorder. Seroquel is considered an atypical antipsychotic.
While AstraZeneca is dealing with more than 10,000 lawsuits over its top-selling drug Seroquel, the FDA has approved the release of Seroquel XR, an extended release form of the drug. It has been approved for the treatment of bipolar disease. It will be used along with the drugs lithium and depakote as a maintenance treatment for bipolar disorder.